- €24.55bn
- €34.01bn
- €28.57bn
- 44
- 61
- 83
- 70
2019 December 31st | R2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13,125 | 13,688 | 24,571 | 38,366 | 28,566 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13,268 | 12,288 | 23,457 | 38,744 | 24,649 |
Operating Profit | -143 | 1,400 | 1,114 | -378 | 3,917 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -752 | 1,265 | 1,522 | 715 | 4,006 |
Provision for Income Taxes | |||||
Net Income After Taxes | -660 | 889 | 832 | 2,992 | 1,597 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8,498 | 1,051 | 721 | 2,717 | 1,450 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8,498 | 1,051 | 721 | 2,717 | 1,450 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.636 | 3.39 | 1.63 | 2.64 | 0.185 |
Dividends per Share |